Will COVID-19 Lead to an Explosion of ME/CFS Cases?

Noting that studies indicated the virus is able to spread throughout the brain including the hypothalamus, Moldofsky proposed the virus had produced a chronic neuroinflammatory state affecting sleep, pain sensitivity and energy levels. That hypothesis, of course, is identical to similar ones proposed for ME/CFS and fibromyalgia.

Source: Will COVID-19 Leave An Explosion of ME/CFS Cases in its Wake? | simmaronresearch.com

The Potential Coronavirus Catastrophe No One is Talking About

The views expressed in this article are purely speculative, there are no known cases currently of ME/CFS being caused by COVID-19.

By not discussing ME as another potential implication of coronavirus, it only adds to the unfolding calamity that the UK, and the planet, could be facing. And moreover, the public needs to be aware of this. Because potentially, for those that get sick with ME after coronavirus, there may be little support available.

Source: The other potential coronavirus catastrophe no one is talking about | The Canary

Early Research on Existing Drug Compounds via Supercomputing Could Combat Coronavirus

Researchers at the Department of Energy’s Oak Ridge National Laboratory have used Summit, the world’s most powerful and smartest supercomputer, to identify 77 small-molecule drug compounds that might warrant further study in the fight against the SARS-CoV-2 coronavirus, which is responsible for the COVID-19 disease outbreak.

Source: Early research on existing drug compounds via supercomputing could combat coronavirus | ORNL

ME/CFS is Debilitating but Often Dismissed

A study by researchers at DePaul University, published in 2019 in Health Care for Women International, surveyed 541 people with ME/CFS and found that 89% had experienced a dismissive attitude from a healthcare provider. People with the condition often encounter insensitivity, inappropriate beliefs about causes, inappropriate treatments, disbelief and a general lack of knowledge, the study says. Because ME/CFS symptoms overlap with so many other disorders, like depression, those who have the condition are often misdiagnosed.

Source: Chronic Fatigue Syndrome Is Debilitating but Often Dismissed

Study: The Prevalence of Pediatric ME

Researchers screened a random sample of 10,119 youth ages 5-17 from 5,622 households. Of those who screened positive over the phone, 165 youth went on to medical and psychiatric examinations. Following evaluations, a team of physicians made final diagnoses. Youth were given a diagnosis of ME/CFS if they met criteria for case definitions. Of the 42 youth diagnosed with ME/CFS, only 2 (4.8%) had been previously diagnosed with the illness.

Source: The Prevalence of Pediatric Myalgic Encephalomyelitis | News | Newsroom | DePaul University, Chicago

NIH Funds Study of CFS and Mono in College Age Students

“This study may help identify risk factors that make certain individuals more likely to develop ME/CFS after an infection and may provide additional insights into biological causes of this debilitating disease,” said Vicky Whittemore, program director at the National Institute of Neurological Disorders and Stroke.

One aim of the new study is to assess the natural history of and risk factors for the maintenance of ME/CFS following infectious mononucleosis (IM).

Source: Press Releases | News | Newsroom | DePaul University, Chicago

Patients Push Limits for Clues to ME/CFS at NIH

null

The NIH study is focusing on people who came down with the disease after an infection, of any sort, within five years. That initial infection is long gone but maybe, the body’s normal reactions to illness went into a destructive tailspin. Nearly 500 patients have called seeking to enroll in NIH’s study that is putting a few dozen under the microscope, with a barrage of sophisticated tests few hospitals can offer under one roof. “The ignorance about the condition just vastly dwarfs what we know about it,” said Dr. Walter Koroshetz, director of NIH’s National Institute for Neurological Disorders and Stroke, which is leading the research.

Source: Patients push limits for clues to chronic fatigue syndrome – STAT

FDA: Gabapentin, Opioid Combination May Cause Breathing Problems

New warnings about the risk of dangerous breathing difficulties when gabapentinoids are used with opioids or by certain patients must now appear on product labels, the U.S. Food and Drug Administration announced Thursday.

Gabapentinoids include: generic gabapentin and brand-name gabapentin marketed as Neurontin and Gralise; gabapentin enacarbil, marketed as Horizant; and generic pregabalin and pregabalin marketed as Lyrica and Lyrica CR.

Source: FDA: Gabapentin, opioid combination may cause breathing problems – UPI.com